A2 Milk share price: the $57 billion market opportunity

We examine why UBS remains bullish on a2 Milk.

Amidst chaos and uncertainty the a2 Milk (A2M) share price had held up surprisingly well.

Indeed, year-to-date the market darling has seen its stock increase some 20% – far outperforming the ASX 200 benchmark.

Commentary from the company’s first-half results likely contributed to this bullishness, with management noting that sales across the first two months of 2H20 were above expectations.

Prudently however, because of the still-unfolding Covid-19 situation, it was flagged that:

‘This is a dynamic situation and at this stage we are unable to quantify the impact, either positively or negatively, for the full year.’

Volatility, after all, runs both ways.

A2 Milk share price: the current outlook

Of course, while it often makes sense for management to provide a conservative outlook – analysts have no such mandate. Namely, as UBS analysts posited in a recent note:

'We believe A2M has continued to perform strongly in 2H20, benefiting from a shift to online channels during the COVID-19 outbreak in China, and upwards pricing trends.’

The investment bank is currently forecasting that A2M’s revenue will hit NZ$1,660 million in FY20.

Adding to this view, UBS has found that the Chinese infant formula market continues to experience robust levels of growth – driven by price opposed to volume – as premium products come to dominate the market.

'For A2M specifically, channel checks suggest strength in the corporate daigou/CBEC channel and further penetration in the offline channel with A2M now in >19,000 China MBS's.’

And maybe most bullishly of all, recent research conducted by the Swiss bank 'suggests the addressable market for A2M in China may be much larger than consensus appreciates (~250b RMB) [or approximately AUD$57.72 billion at the current exchange rate], suggesting the sales opportunity is greater.’

Unsurprisingly, UBS currently has a Buy rating and a 12-month price target of NZ$18.50 on a2 Milk.

Other bits and pieces

In other news, on 23 March, a2 Milk announced that it had increased its investment in Synlait milk: from 17.4% to 19.84%. Speaking of this decision – A2M’s Chief Executive Officer – Mr Geoffrey Babidge said:

‘Following the recent decline in Synlait's share price, we view this as an opportunity to complete our strategic holding. Our shareholding reflects the importance to us of our commercial supply arrangements with Synlait.’

The company flagged that it had no intention to further increase its position in Synlait.

At the time of writing, Synlait Milk (SM1) traded at $6.93 per share; while a2 Milk (A2M) traded at $16.98 per share.

How to trade a2 Milk: long or short

What do you make of this: does a2 Milk still have room to run higher or are declines on the horizon. Wherever you stand, you can use IG’s world-class trading platform to go long or short – on a large range of financial instruments, including equities, currencies and indices.

For example, to buy (long) or sell (short) A2 Milk using CFDs, follow these simple steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘a2 Milk’ or ‘A2M’ in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.